Conectus
From the laboratory to the market
launching innovations for a better world!

Since 2012, SATT Conectus has been detecting inventions that originate in Alsace's public research laboratories and investing financially in their technological development. Our objective: to transfer these innovative technologies to companies in order to industrialize them and launch them on the market.

The innovative technologies supported by Conectus

Developing a new therapy against cancer, countering antibiotic resistance, making a window "smart", developing a new waterproofing treatment, imagining a new detector for pollutants in ambient air, treating the adverse effects of chemotherapies... Each year, some fifteen innovative projects led by Alsatian researchers benefit from a financial investment from Conectus (up to €500k/project) to gain in maturity and become innovative products or services accessible to all on the market.

Conectus, how does it works ? (EN)
Play video
Conectus and tech transfer, how does it works ?

 

In which areas does Conectus invest in innovative projects?

Health(1)

Medical technologies

Chemicals / Materials

Santé

47 %

Robot

12 %

Chimie

16 %

Engineering(2)

Energy / ecotechnologies

Digital(3)

Innovation

10%

Soleil

8 %

Cloud computing

6 %

173

technology transfers since 2012

Results are in!

154

innovative projects supported by Conectus since 2012

50 M€

invested by Conectus in innovative projects since 2012

327 k€

invested on average per innovative project (year 2017)

173

technology transfers since 2012

34 %

of innovative projects are developed in co-conception

+ de 18 M€

of revenues from cumulative technology transfers since 2012

361

active intellectual property titles managed 

83 %

innovative projects that have benefited companies established in France

Do you really want to remove this technology from your list ?
close